Table 3

Clinical Outcomes at 12-Month Follow-Up (N = 100)

TLF5.0 (5/100)
TVF5.0 (5/100)
TV-MI3.0 (3/100)
MACE5.0 (5/100)
Cardiac death0.0 (0/100)
Noncardiac death0.0 (0/100)
Cardiac death or TV-MI3.0 (3/100)
TLR2.0 (2/100)
TVR2.0 (2/100)
Stent thrombosis (ARC) definite/probable0.0 (0/100)
 Early thrombosis (≤30 days)0.0 (0/100)
 Late thrombosis (31–360 days)0.0 (0/100)

ARC = Academic Research Consortium; MACE = major adverse cardiac event(s); TLF = target lesion failure; TVF = target vessel failure; TV-MI = target vessel myocardial infarction.

Values are % (n/N).